Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Dr. Lillian Kuo has expertise in immunology and virology, microscopy for cancer, vesicle biology, and molecular biology related to antitumor immunity. She manages a portfolio of grants focusing on basic research in immuno-oncology. 

Along with her DCB responsibilities, Dr. Kuo is a Coordinator of a Cancer Moonshot Implementation Team.

Research Programs 

Dr. Kuo is also involved with NCI and NIH Common Fund programs:

Background

Prior to DCB, Dr. Kuo worked as a program officer at the National Institute of Allergy and Infectious Diseases (NIAID).

She came to DCB because of the science-forward philosophy and scientific opportunities for collaboration in the division.

Education

  • Ph.D., Pharmacology, University of Texas Southwestern Medical Center  
  • B.S., Bacteriology and Genetics, University of Wisconsin-Madison 
Email